Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
about
Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication.Approved Antiviral Drugs over the Past 50 YearsNuclear export and import of human hepatitis B virus capsid protein and particlesDe-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription.Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approachReconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coliA cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication.The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surfaceEfficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein.Vaccination against a hit-and-run viral cancer.Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteinsHepatitis B Virus Genotype G forms core-like particles with unique structural properties.Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinomaDiversity of core antigen epitopes of hepatitis B virusPreparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.Localization of the N terminus of hepatitis B virus capsid protein by peptide-based difference mapping from cryoelectron microscopy.High-resolution mass spectrometry of viral assemblies: molecular composition and stability of dimorphic hepatitis B virus capsids.Autoantibodies to tumor-associated antigens: reporters from the immune system.Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.Stability and shape of hepatitis B virus capsids in vacuo.Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system.HBV maintains electrostatic homeostasis by modulating negative charges from phosphoserine and encapsidated nucleic acidsRecent advances in molecular diagnostics of hepatitis B virus.dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases.Infection-related cancers in sub-saharan Africa: a paradigm for cancer prevention and control.Keratin 8 is involved in hepatitis B virus replication.Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation.Mapping of homologous interaction sites in the hepatitis B virus core protein.Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.Diagnostic virology and patient care: from vaguely interesting to vitally important.Human liver chimeric mouse model based on diphtheria toxin-induced liver injuryGenotypes and S-gene variability of Mexican hepatitis B virus strains.Antiviral effects of PNA in duck hepatitis B virus infection model.Significant interference with hepatitis B virus replication by a core-nuclease fusion protein.Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids.The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary.
P2860
Q21144733-6B9EAEE1-23F0-4EA3-BFE6-EBF8F2E2A163Q27755387-CC349D67-2B3F-4E34-BC9F-5ABC3EE25F7FQ28475960-753947EB-4DB6-4BE6-A188-6932562A620FQ31938591-17F96C8C-2154-4507-A4C6-7B79D8BD5285Q33206025-767388B1-DC46-4352-9115-C3157B7CE7EDQ33648943-A2820AFA-B431-48B1-9072-756C36143455Q33852684-6B7AA9C1-5E4C-4BF3-8277-84DBB1BBCB82Q33895863-6ECBDF74-433A-44BB-B2C3-266378326F8FQ34085801-243E3D5E-2044-428E-8E74-BAF752357391Q34085995-138DFB91-4724-4063-8072-BC82D2F6C560Q34212832-4B3F0DD0-B428-462D-AAAD-276E0A024C1DQ34641583-6AAD210D-B422-4482-ACE3-5F6E2801EB77Q35010703-EBFCACBE-63AB-4F2A-A111-9B5C172549F3Q35048510-5962D49F-429E-4C46-BBF2-F2385067322EQ35677500-5437E2A2-7EFA-434F-A275-64746B8B7272Q35978599-E58C201E-E4D2-42AB-A231-C47E2D33DFF4Q36083061-6AEE3684-A6BB-4324-A35C-7EEF1D411DA9Q36752843-39499B87-54C6-4CEA-B726-EF138F7A053DQ36756811-C301BC9A-E711-484E-8FC3-AC80214C46DBQ37118192-ED1A9154-B8A8-4066-89FE-C5690C37624CQ37163704-35FB80B7-82B9-4D99-AC6E-B253E3F051F6Q37252915-A8B697FC-EABF-4137-ADA7-206551F27417Q37359983-01CBB2FA-E96F-4C10-810A-0855E75689A1Q37365388-196DE788-894D-4822-9A12-89A148A35A05Q37498902-50FBB7A6-9BD9-4512-ADC7-FE4593CDC677Q38263846-00A38680-C366-4317-A053-A90D0DF2D370Q38290803-08D82E7D-B9C7-458C-99E7-C4A70B8B0D21Q38866854-D3422822-F47F-43FD-989D-2B040E39B07CQ39038775-7A5F7148-7F9E-4867-ADD2-48606B509306Q39551837-5801BF8C-55D7-4919-8943-D2F2266D0322Q39580757-FE519621-34B7-4273-B10A-C04C139F4A85Q39601760-2DBCDC37-28E0-434C-B07C-F33E7292048EQ40330308-6A2268C2-CA80-4BC7-9F25-8767A5BE8987Q41122418-DCEE189C-04F8-4787-9519-222320A1456FQ44646490-4A58D175-1BA3-4F34-9BCF-D2DD61180051Q45399993-C576D664-B9A1-445A-84E2-CF4B5BC41362Q45739285-7D63376D-B9AB-406B-8ED5-F51EF6DA4FB5Q45740585-540521B4-438B-4AC6-8A2E-9B6490707333Q47129496-43EED77B-0A20-4BD5-B3A6-7022870821FA
P2860
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@ast
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@en
type
label
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@ast
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@en
prefLabel
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@ast
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@en
P2860
P356
P1476
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
@en
P2093
B S Blumberg
P2860
P304
P356
10.1073/PNAS.94.14.7121
P407
P577
1997-07-01T00:00:00Z